Nathan Smith - 07 Aug 2025 Form 4 Insider Report for CareDx, Inc. (CDNA)

Reporting relationship: Chief Financial Officer
Issuer ticker: CDNA
Reported as of: 07 Aug 2025
Net transaction value: $0
SEC form: 4
Accepted by SEC: 11 Aug 2025, 16:35:25 UTC
Next SEC filing: 04 Feb 2026
Source filing: View source filing
Reporting owner signature: /s/ Jeffrey Adam Novack, Attorney-in-Fact

Key filing fact

Nathan Smith filed Form 4 for CareDx, Inc. (CDNA) on 11 Aug 2025.

Key facts

This page summarizes Nathan Smith's Form 4 filing for CareDx, Inc. (CDNA).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 11 Aug 2025, 16:35.

Change

No earlier filing in this sequence is available for direct comparison.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0002079385 Primary reporting owner

SMITH NATHAN

Relationship: Chief Financial Officer
Address: C/O CAREDX, INC., 8000 MARINA BLVD., 4TH FLOOR, BRISBANE
Signature: /s/ Jeffrey Adam Novack, Attorney-in-Fact
Signature date: 11 Aug 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CDNA transaction

Common Stock

Award

Transaction value: $0
Shares: +42,000
Change %
Price: $0.000000
Shares after: 42,000
Date: 07 Aug 2025
Ownership: Direct
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

The reported securities are represented by restricted stock units ("RSUs"). Pursuant to the terms of the RSU, 25% of the total number of shares underlying the RSU shall vest on August 7, 2026, and 1/16th of the total number of shares underlying the RSU shall vest in quarterly installments thereafter until fully vested, subject to the Reporting Person's continued service to the Issuer on each vesting date.

Footnote F2

Each RSU represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration.